cancer imaging agents (MallincKrodt/Optimedx)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namecancer imaging agents (MallincKrodt/Optimedx)
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMallinckrodt Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOptimedxMallinckrodt Plc
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A